This website is intended for a US audience.

Fewer Seizures in Those Hardest to Treat

The efficacy and safety profile of EPIDIOLEX was established in the largest placebo-controlled, clinical study program in Dravet and LGS completed to date. It included patients whose seizures were uncontrolled despite multiple seizure medicines, defining them as highly treatment resistant.

Those participating in the studies had typically failed 4 to 6 prior seizure medicines. These patients were also taking 3 seizure medicines at the time, but their seizures were still uncontrolled.